Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Moore

Showing results (61-70 of 500) with videos related to

Pageof 50
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2013
The impact of combined antiretroviral therapy on biologic false-positive rapid plasma reagin serologies in a longitudinal cohort of HIV-infected personsIkwo K Oboho, Kelly A Gebo, Richard D Moore, et al.
BMC Developmental Biology|January 25, 2013
Plasma membrane events associated with the meiotic divisions in the amphibian oocyte: insights into the evolution of insulin transduction systems and cell signalingGene A Morrill, Adele B Kostellow, Richard D Moore, et al.
AIDS Patient Care and Stds|February 12, 2008
A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohortDavid J Riedel, Kelly A Gebo, Richard D Moore, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2004
Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infectionKelly A Gebo, Joel E Gallant, Jeanne C Keruly, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 7, 2012
Herpes zoster among persons living with HIV in the current antiretroviral therapy eraLeah J Blank, Michael J Polydefkis, Richard D Moore, et al.
Preventive Medicine|May 12, 2024
Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000-2020Filip Pirsl, Jeanne C Keruly, Richard D Moore, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 7, 2017
Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed IndividualsKeri L Calkins, Catherine R Lesko, Geetanjali Chander, et al.
Journal of Clinical Epidemiology|December 26, 2008
Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiatorsBryan E Shepherd, Timothy R Sterling, Richard D Moore, et al.
Annals of Family Medicine|November 9, 2021
Clinician Response to Patient Emotion: Impact on Subsequent Communication and Visit LengthMary Catherine Beach, Jenny Park, Dingfen Han, et al.
BMC Medical Research Methodology|March 11, 2018
An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug useKeri L Calkins, Chelsea E Canan, Richard D Moore, et al.
Pageof 50

Showing results (61-70 of 500) with videos related to

Sort By:
Pageof 50
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2013
The impact of combined antiretroviral therapy on biologic false-positive rapid plasma reagin serologies in a longitudinal cohort of HIV-infected personsIkwo K Oboho, Kelly A Gebo, Richard D Moore, et al.
BMC Developmental Biology|January 25, 2013
Plasma membrane events associated with the meiotic divisions in the amphibian oocyte: insights into the evolution of insulin transduction systems and cell signalingGene A Morrill, Adele B Kostellow, Richard D Moore, et al.
AIDS Patient Care and Stds|February 12, 2008
A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohortDavid J Riedel, Kelly A Gebo, Richard D Moore, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2004
Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infectionKelly A Gebo, Joel E Gallant, Jeanne C Keruly, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 7, 2012
Herpes zoster among persons living with HIV in the current antiretroviral therapy eraLeah J Blank, Michael J Polydefkis, Richard D Moore, et al.
Preventive Medicine|May 12, 2024
Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000-2020Filip Pirsl, Jeanne C Keruly, Richard D Moore, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 7, 2017
Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed IndividualsKeri L Calkins, Catherine R Lesko, Geetanjali Chander, et al.
Journal of Clinical Epidemiology|December 26, 2008
Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiatorsBryan E Shepherd, Timothy R Sterling, Richard D Moore, et al.
Annals of Family Medicine|November 9, 2021
Clinician Response to Patient Emotion: Impact on Subsequent Communication and Visit LengthMary Catherine Beach, Jenny Park, Dingfen Han, et al.
BMC Medical Research Methodology|March 11, 2018
An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug useKeri L Calkins, Chelsea E Canan, Richard D Moore, et al.
Pageof 50